Who We Are
Cognition Therapeutics, Inc. is a clinical stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. Cognition’s mission is to stop the unrelenting progression of neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, and dementia with Lewy bodies (DLB), and by doing so alter the impact of the societal tsunami of these fatal diseases.
Who We Serve
Languages Spoken
English
Service Area(s)
Nationwide
Age Requirements
No Age Requirement
Available 24/7
No
Intake Process
Call or email for information.
Self Refer
Yes
Provider Refer
Yes
Intake Contact Telephone
(412) 481-2210
Report Problems
Call the Agency